LoQus23 Therapeutics

DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease.

HQ location

Cambridge, United Kingdom

Website

Launch date

Mar 2019

Employees

Enterprise value

$185—277m

Company register number

https://x.com/loqus23 https://www.linkedin.com/company/loqus23-therapeutics-ltd/

Authorizing premium user...